Research ArticleCellular and Molecular
Downregulation of Ca2+-Activated Cl− Channel TMEM16A by the Inhibition of Histone Deacetylase in TMEM16A-Expressing Cancer Cells
Sayo Matsuba, Satomi Niwa, Katsuhiko Muraki, Saki Kanatsuka, Yurika Nakazono, Noriyuki Hatano, Masanori Fujii, Peng Zhan, Takayoshi Suzuki and Susumu Ohya
Journal of Pharmacology and Experimental Therapeutics December 2014, 351 (3) 510-518; DOI: https://doi.org/10.1124/jpet.114.217315
Sayo Matsuba
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Satomi Niwa
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Katsuhiko Muraki
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Saki Kanatsuka
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Yurika Nakazono
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Noriyuki Hatano
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Masanori Fujii
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Peng Zhan
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Takayoshi Suzuki
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
Susumu Ohya
Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.M., S.N., S.K., Y.N., M.F., S.O.); Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, Nagoya, Japan (K.M., N.H.); and Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan (P.Z., T.S.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleCellular and Molecular
Downregulation of TMEM16A by HDAC3 Inhibition
Sayo Matsuba, Satomi Niwa, Katsuhiko Muraki, Saki Kanatsuka, Yurika Nakazono, Noriyuki Hatano, Masanori Fujii, Peng Zhan, Takayoshi Suzuki and Susumu Ohya
Journal of Pharmacology and Experimental Therapeutics December 1, 2014, 351 (3) 510-518; DOI: https://doi.org/10.1124/jpet.114.217315
Research ArticleCellular and Molecular
Downregulation of TMEM16A by HDAC3 Inhibition
Sayo Matsuba, Satomi Niwa, Katsuhiko Muraki, Saki Kanatsuka, Yurika Nakazono, Noriyuki Hatano, Masanori Fujii, Peng Zhan, Takayoshi Suzuki and Susumu Ohya
Journal of Pharmacology and Experimental Therapeutics December 1, 2014, 351 (3) 510-518; DOI: https://doi.org/10.1124/jpet.114.217315
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement